Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$45,000.00

Integrity of the cellular transformation barriers in reprogrammed cell

FY 2023-24

Summary
Pluripotent stem cells can differentiate in any cell type and have an unlimited capacity to proliferate. These characteristics make these cells very attractive for studying various cellular functions and differentiation pathways. Thanks to a robust protocol established by Shinya Yamanaka (Nobel prize in 2012) it is now possible to generate induced pluripotent stem cells (iPSC) from any somatic cells. This reprogramming protocol only requires the transient expression of 4 different genes which epigenetically modify cells allowing them to acquire and maintain the state of pluripotence. Although robust and reproducible, this procedure is highly inefficient (typically less than 0.01%) with only few iPSC clones emerging. It was shown that inactivation of the tumor suppressor genes TP53 and Ink4a greatly increases the reprogramming success and it is now believed that transient inactivation of these genes occurs during reprogramming. How these genes are regulated during that process and more importantly whether their numerous functions are maintained in reprogrammed cells is mostly unknown. This information is important because iPSC-derived cells (i.e. neurons and cardiomyocytes) are routinely used for drug discovery and as a tool to study cell biology principles and molecular mechanisms. As such, the goal of our research program is to evaluate the integrity of cellular senescence, apoptosis and DNA repair processes in iPSC-derived cells. Our hypothesis is that cellular reprogramming may lead to abnormal tumor suppressive functions making iPSC-derived cells more prone to cell transformation. More specifically we propose to: 1.Evaluate the ability of iPSC-derived cells to activate the senescence and apoptosis pathways in response to DNA damage and oncogene expression. 2.Evaluate the ability of iPSC-derived cells to proceed to DNA repair (i.e. homologous recombination and none homologous end-joining) in response to a DNA damage. 3.Measure to propensity of iPSC-derived cells to transform following exposure to mutagenic drugs. This research program will reveal whether the integrity of key molecular mechanisms involved in cellular transformation and DNA repair are intact in reprogrammed cells. The long term goals/impacts of this proposal will be improved reprogramming strategies to better preserve genetic integrity and reduce the risks of cellular transformation. The results of this program will be applicable to nearly all laboratories using iPSCs for drug discovery or for studying basic cellular functions/pathways.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2023-03683
Name nom
Beauséjour, Christian
Department département
pharmacologie et physiologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
45000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Integrity of the cellular transformation barriers in reprogrammed cell
Keyword
Apoptosis; DNA repair; induced pluripotent stem cells; Senescence
Application summary
Pluripotent stem cells can differentiate in any cell type and have an unlimited capacity to proliferate. These characteristics make these cells very attractive for studying various cellular functions and differentiation pathways. Thanks to a robust protocol established by Shinya Yamanaka (Nobel prize in 2012) it is now possible to generate induced pluripotent stem cells (iPSC) from any somatic cells. This reprogramming protocol only requires the transient expression of 4 different genes which epigenetically modify cells allowing them to acquire and maintain the state of pluripotence. Although robust and reproducible, this procedure is highly inefficient (typically less than 0.01%) with only few iPSC clones emerging. It was shown that inactivation of the tumor suppressor genes TP53 and Ink4a greatly increases the reprogramming success and it is now believed that transient inactivation of these genes occurs during reprogramming. How these genes are regulated during that process and more importantly whether their numerous functions are maintained in reprogrammed cells is mostly unknown. This information is important because iPSC-derived cells (i.e. neurons and cardiomyocytes) are routinely used for drug discovery and as a tool to study cell biology principles and molecular mechanisms. As such, the goal of our research program is to evaluate the integrity of cellular senescence, apoptosis and DNA repair processes in iPSC-derived cells. Our hypothesis is that cellular reprogramming may lead to abnormal tumor suppressive functions making iPSC-derived cells more prone to cell transformation. More specifically we propose to: 1.Evaluate the ability of iPSC-derived cells to activate the senescence and apoptosis pathways in response to DNA damage and oncogene expression. 2.Evaluate the ability of iPSC-derived cells to proceed to DNA repair (i.e. homologous recombination and none homologous end-joining) in response to a DNA damage. 3.Measure to propensity of iPSC-derived cells to transform following exposure to mutagenic drugs. This research program will reveal whether the integrity of key molecular mechanisms involved in cellular transformation and DNA repair are intact in reprogrammed cells. The long term goals/impacts of this proposal will be improved reprogramming strategies to better preserve genetic integrity and reduce the risks of cellular transformation. The results of this program will be applicable to nearly all laboratories using iPSCs for drug discovery or for studying basic cellular functions/pathways.